Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

EXPRESS SCRIPTS HOLDING CO (ESRX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
Stocks mentioned in the article
ChangeLast1st jan.
EXPRESS SCRIPTS HOLDING CO 0.12% 80.58 Delayed Quote.7.82%
UNITEDHEALTH GROUP -0.73% 253.02 Delayed Quote.16.11%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
06/13MARKETS RIGHT NOW : Stocks slip after Fed raises rates
AQ
06/13Investors In Health Care Mergers Cheer Judge's OK Of AT&T-Time Warner Deal
AQ
06/07U.S. antitrust official says worries over limiting vertical deals 'misplaced'
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
06/07CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture
RE
06/07EXPRESS SCRIPTS : to Provide Patients with Faster Path to Rare Disease Diagnosis..
AQ
06/07EXPRESS SCRIPTS' : Physician-Minded Solutions Deliver Greater Price Transparency..
PU
06/06EXPRESS SCRIPTS : invests firm that makes self-serve pharmacy kiosks
AQ
06/06PHARMACY EVERYWHERE : Express Scripts and MedAvail Announce Collaboration to Mak..
PU
06/04EXPRESS SCRIPTS : There Might Be a Cheaper Drug, But Pharmacists Can't Tell You ..
AQ
More news
News from SeekingAlpha
06/18Will AT&T/Time Warner Ruling Accelerate M&A? 
06/13PREMARKET GAINERS AS OF 9 : 05 am (06/13/2018) 
06/13Headlines Don't Determine Stock Prices - Cramer's Mad Money (6/12/18) 
06/12After Hours Gainers / Losers (06/12/2018) 
06/12Mega-merger healthcare players up on positive court ruling for AT&T/Time Warn.. 
Financials ($)
Sales 2018 101 B
EBIT 2018 7 351 M
Net income 2018 3 826 M
Debt 2018 9 321 M
Yield 2018 -
P/E ratio 2018 12,63
P/E ratio 2019 11,10
EV / Sales 2018 0,54x
EV / Sales 2019 0,49x
Capitalization 45 207 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 85,1 $
Spread / Average Target 5,6%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Neal Sample Chief Operating Officer & Executive Vice President
James M. Havel Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO7.82%45 921
CVS HEALTH CORPORATION-3.32%71 257
WALGREENS BOOTS ALLIANCE-9.39%65 252
MCKESSON CORPORATION-6.35%30 308
AMERISOURCEBERGEN-0.27%20 848
CARDINAL HEALTH-10.64%17 010